This study aimed to determine the optimal timing for specimen collection by comparing PD‐L1 and PD‐L2 expression between naive and recurrent tumors, including those with multiple recurrence sites, using paired biopsy specimens from patients with R/M HNSCC. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.